TNFSF10 and metabolic dysfunction-associated steatotic liver disease: Our findings show for the first time that deletion of TRAIL causes systemic insulin resistance, increases hepatic cholesterol and glucose production and renders the liver more susceptible to triglyceride accumulation and injury, promoting a more severe form of NAFLD in response to a HFD.